Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis

European Respiratory Journal

Volumn 39, Issue 3, 2012, Pages 777-780

  Ohashi, K ^a,b   Sato, A ⁿ   Takada, T ^b   Arai, T ^c   Kasahara, Y ^d   Hojo, M ^e   Nei, T ^a   Nakayama, H ^b   Motoi, N ^a   Urano, S ^a   Eda, R ^g,h   Yokoba, M ⁱ   Tsuchihashi, Y ^j   Nasuhara, Y ^k   Ishii, H ^f   Ebina, M ^l   Yamaguchi, E ^m   Inoue, Y ^c   Nakata, K ^a   Tazawa, R ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL SANYO HOSPITAL   (Japan)

^h Department of Medicine   (Japan)

ⁱ KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NAGASAKI UNIVERSITY   (Japan)

^k HOKKAIDO UNIVERSITY   (Japan)

^l TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; LUNG SURFACTANT;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; AUTOIMMUNE DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LETTER; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG CLEARANCE; LUNG FUNCTION TEST; LUNG LAVAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 84860344087     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00076711     Document Type: Letter

References (11)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-1142.
2. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-880. (Pubitemid 29451632)
3. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215-235. (Pubitemid 34765459)
4. Sakagami T, Beck D, Uchida K, et al. Patient-derived granulocyte/ macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med 2010; 182: 49-61.
5. Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 524-531. (Pubitemid 32158540)
6. Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 2006; 130: 227-237. (Pubitemid 44116865)
7. Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005; 171: 1142-1149. (Pubitemid 40663727)
8. Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol 2002; 105: 342-350. (Pubitemid 36016062)
9. Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage- colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2010; 181: 1345-1354.
10. Uchida K, Nakata K, Suzuki T, et al. Granulocyte/macrophage-colony- stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 2009; 113: 2547-2556.
11. Bonfield TL, Raychaudhuri B, Malur A, et al. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1132-L1136. (Pubitemid 37310102)